Michael Scordo (@mscordomd) 's Twitter Profile
Michael Scordo

@mscordomd

Hematologist & Oncologist / Hematopoietic Cell Transplantation & Cellular Therapy / Lymphoma & Multiple Myeloma / MSKCC

ID: 1173667514041143297

linkhttps://www.mskcc.org/cancer-care/doctors/michael-scordo?amp calendar_today16-09-2019 18:40:05

328 Tweet

996 Followers

375 Following

Michael Scordo (@mscordomd) 's Twitter Profile Photo

Awesome luncheon debate at #MSKToxTCT Should we always try to achieve remission in AML prior to allo HCT? Yes/No mskcc.org/toxicities MSK CME

Awesome luncheon debate at #MSKToxTCT Should we always try to achieve remission in AML prior to allo HCT? Yes/No mskcc.org/toxicities <a href="/MSKCME/">MSK CME</a>
Kate Cwynarski (@cwynkate) 's Twitter Profile Photo

Such progress in Rx of #PCNSL & #SCNSL #17ICML Thx to ⁦#AndresFerreri ⁦⁦Gerald IllerhausElisabeth Schorb ⁦@DrChrisPFox⁩ ⁦Jessica Okosun⁩ ⁦Claire Roddie⁩ #LakshmiNayak #CaroleSoussain & @ jahanzaibkhwaja for his thoughtful input👏 onlinelibrary.wiley.com/doi/10.1002/ho…

Nature Reviews Disease Primers (@diseaseprimers) 's Twitter Profile Photo

Our NEW Primer on Primary central nervous system lymphoma is live today! By Ferreri, Calimeri, Kate Cwynarski, Dietrich, Grommes, Hoang-Xuan, Hu, Gerald Illerhaus, Nayak, Ponzoni & Batchelor. Check it out here: go.nature.com/3PhmY5Y

NMDP (@nmdp_org) 's Twitter Profile Photo

Let's show some love to Grammy award-winning artist jon batiste on the release of his new album and for using his platform to reach beyond the music to help us grow the blood stem cell donor registry! 💙💚 Feeling inspired? Become a potential lifesaver 👉 my.bethematch.org/Susu

Memorial Sloan Kettering Cancer Center (@mskcancercenter) 's Twitter Profile Photo

In Feb. 2022, suleika jaouad received a bone marrow transplant (BMT) at MSK, 13 years after she was first treated for acute myeloid leukemia. Read her story and find out how you can get involved with the “American Symphony: Become a Lifesaver” campaign: bit.ly/3R69Pfd

In Feb. 2022, <a href="/SuleikaJaouad/">suleika jaouad</a> received a bone marrow transplant (BMT) at MSK, 13 years after she was first treated for acute myeloid leukemia. Read her story and find out how you can get involved with the “American Symphony: Become a Lifesaver” campaign: bit.ly/3R69Pfd
NMDP (@nmdp_org) 's Twitter Profile Photo

Inspired by Matthew Heineman's film #AmericanSymphony about jon batiste and @suleikajaouad's leukemia journey? Us too! #JoinTheSymphony with Barack Obama and Memorial Sloan Kettering Cancer Center to help patients access the life-saving blood stem cell transplants they need 👉 bit.ly/41Zrdr9

Memorial Sloan Kettering Cancer Center (@mskcancercenter) 's Twitter Profile Photo

Inspired by Matthew Heineman's film #AmericanSymphony about jon batiste and @suleikajaouad's leukemia journey? #JoinTheSymphony along with Barack Obama and NMDP to help patients access the life-saving blood stem cell transplants they need 👉 bit.ly/3N4HyVg

Memorial Sloan Kettering Cancer Center (@mskcancercenter) 's Twitter Profile Photo

Results from a large retrospective study co-led by MSK and published in Journal of Clinical Oncology show that PTCy is an acceptable alternative to CNI-based #prophylaxis in MUD HCT recipients and superior for MMUD HCT. Learn more: mskcc.org/clinical-updat…

Results from a large retrospective study co-led by MSK and published in <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> show that PTCy is an acceptable alternative to CNI-based #prophylaxis in MUD HCT recipients and superior for MMUD HCT.

Learn more: mskcc.org/clinical-updat…
ASTCT (@astct) 's Twitter Profile Photo

ASTCT is currently accepting abstracts for the Toxicities Conference, allowing you to present your research to an international audience. The top five best abstracts will receive complimentary registration to the conference. Submit by August 26: ow.ly/3VgN50SGyn9

ASTCT is currently accepting abstracts for the Toxicities Conference, allowing you to present your research to an international audience. The top five best abstracts will receive complimentary registration to the conference. Submit by August 26: ow.ly/3VgN50SGyn9
Brandon Imber (@brandon_imber) 's Twitter Profile Photo

Active CNS 🧠 disease is a major challenge for #lymphoma pts planned for CAR T cells. CNS bridging #radiotherapy can rapidly cytoreduce these high risk pts. The Memorial Sloan Kettering Cancer Center initial experience out in Blood Advances Memorial Sloan Kettering Radiation Oncology ashpublications.org/bloodadvances/…

ASTCT (@astct) 's Twitter Profile Photo

Deadline tomorrow 🚨 Share your findings on toxicities with global experts at #ToxicitiesConference24. Topics include solid organ malignancies, machine learning, novel approaches to improve outcomes, among others. Learn more & submit by Sept. 8: ow.ly/KCFr50T735J

Deadline tomorrow 🚨 Share your findings on toxicities with global experts at #ToxicitiesConference24. Topics include solid organ malignancies, machine learning, novel approaches to improve outcomes, among others. 

Learn more &amp; submit by Sept. 8: ow.ly/KCFr50T735J
ASTCT (@astct) 's Twitter Profile Photo

The #ToxicitiesConference24 will bring together experts & thought leaders to address the latest advances in preventing & treating toxicities after HCT, cell & gene therapies. Join us November 15-16 in Philadelphia or virtually. View the agenda & register: ow.ly/cAxP50TBR4f

The #ToxicitiesConference24 will bring together experts &amp; thought leaders to address the latest advances in preventing &amp; treating toxicities after HCT, cell &amp; gene therapies. Join us November 15-16 in Philadelphia or virtually. View the agenda &amp; register: ow.ly/cAxP50TBR4f
ASTCT (@astct) 's Twitter Profile Photo

The #ToxicitiesConference24 will bring together experts & thought leaders to address the latest advances in preventing & treating toxicities after HCT, cell & gene therapies. Join us November 15-16 in Philadelphia or virtually. View the agenda & register: ow.ly/cAxP50TBR4f

The #ToxicitiesConference24 will bring together experts &amp; thought leaders to address the latest advances in preventing &amp; treating toxicities after HCT, cell &amp; gene therapies. Join us November 15-16 in Philadelphia or virtually. View the agenda &amp; register: ow.ly/cAxP50TBR4f